Genetic architecture of prostate cancer in the Ashkenazi Jewish population
Open Access
- 9 August 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (6) , 864-869
Abstract
Recently, numerous prostate cancer risk loci have been identified, some of which show association in specific populations. No study has yet investigated whether these single nucleotide polymorphisms (SNPs) are associated with prostate cancer in the Ashkenazi Jewish (AJ) population. A total of 29 known prostate cancer risk SNPs were genotyped in 963 prostate cancer cases and 613 controls of AJ ancestry. These data were combined with data from 1241 additional Ashkenazi controls and tested for association with prostate cancer. Correction for multiple testing was performed using the false discovery rate procedure. Ten of twenty-three SNPs that passed quality control procedures were associated with prostate cancer risk at a false discovery rate of 5%. Of these, nine were originally discovered in studies of individuals of European ancestry. Based on power calculations, the number of significant associations observed is not surprising. We see no convincing evidence that the genetic architecture of prostate cancer in the AJ population is substantively different from that observed in other populations of European ancestry.Keywords
This publication has 30 references indexed in Scilit:
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyNature Genetics, 2009
- Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibilityNature Genetics, 2009
- Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Proceedings of the National Academy of Sciences, 2008
- Multiple newly identified loci associated with prostate cancer susceptibilityNature Genetics, 2008
- Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerNature Genetics, 2008
- Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesNature Genetics, 2007
- Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24Nature Genetics, 2007
- A common variant associated with prostate cancer in European and African populationsNature Genetics, 2006
- Genetic Signatures of Strong Recent Positive Selection at the Lactase GeneThe American Journal of Human Genetics, 2004
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society Series B: Statistical Methodology, 1995